Schizophrenia Research and Treatment / 2013 / Article / Tab 2

Clinical Study

Cognitive Training for Schizophrenia in Developing Countries: A Pilot Trial in Brazil

Table 2

Results at after intervention in the CT and control groups and effect-sizes.

Experimental
mean ± SE
Control
mean ± SE
Between groups
Within groups
Interaction Effect-size
(Cohen's

Positive and negative syndrome scale for schizophrenia
Negative subscale
 Baseline 0.3030.3580.7530.877
 Post
Positive subscale
 Baseline 0.6100.0120.9350.000
 Post
General psychopathology subscale
 Baseline 0.5760.0440.5810.486
 Post
Total score
 Baseline 0.5990.2750.7600.263
 Post

Neuropsychological measures
Trail Making A
 Baseline 0.9030.0030.0190.821
 Post
Trail Making B
 Baseline 0.9000.0450.4270.272
 Post
Stroop Test Card I
 Baseline 0.7560.3430.7990.691
 Post
Stroop Test Card II
 Baseline 0.3340.0010.9300.015
 Post
Stroop Test Card III
 Baseline 0.9580.5530.0361.549
 Post
MWCST total categories
 Baseline 0.562 0.4780.0671.177
 Post
MWCST perseverative errors
 Baseline 0.5490.0460.3950.134
 Post
MWCST failure to maintain set
 Baseline 0.7020.7450.0101.086
 Post
Logical memory I
 Baseline 0.8540.4680.6800.199
 Post
Logical memory II
 Baseline 0.8020.6430.0031.618
 Post
Visual reproduction I
 Baseline 0.3780.1570.4040.261
 Post
Visual reproduction II
 Baseline 0.0530.0720.1031.127
 Post

Interaction: groups time.
SE: standard error.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.